Augmedix, Inc.
Augmedix, Inc. (AUGX) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
augx · stock forecast · 6 analysts (3M) · FMP · updated Mar 24, 2025
Analyst Rating & Consensus
Based on 6 Wall Street analysts in the past 3 months
Buy
6 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$3.50
Consensus
$2.67
+13.6% upside
Low
$1.50
Median: $3 · Last Close: $2.35
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$2.67
13.6% upside
High Target
$3.5
48.9%
Low Target
$1.5
-36.2%
Current Price
$2.35
as of today
Based on analyst price targets, the AUGX stock price prediction for the next 12 months ranges from $1.5 to $3.5. The consensus AUGX price forecast of $2.67 implies 13.6% upside from the current price of $2.35.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $2.35 | ↑ 0.12% |
1-day model range: $2.35–$2.35. Peak: $2.35 (+0.12%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · AUGX · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2024-07-22 | Lake Street | Downgrade ↓ | Buy→Hold |
| 2024-05-14 | Maxim Group | Downgrade ↓ | Buy→Hold |
| 2024-05-14 | Lake Street | Maintains | Buy→Buy |
| 2024-04-09 | Evercore ISI Group | Upgrade ↑ | In Line→Outperform |
| 2024-03-19 | Evercore ISI Group | Maintains | In Line→In Line |
| 2024-03-19 | Maxim Group | Maintains | Buy→Buy |
| 2023-05-16 | Benchmark | Maintains | Buy→Buy |
| 2023-05-15 | B. Riley Securities | Maintains | Buy→Buy |
| 2023-05-15 | Benchmark | Maintains | Buy→Buy |
| 2023-05-14 | B. Riley Securities | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Augmedix, Inc. (AUGX) stock. Of the recent 23 rating actions, 1 were upgrades and 2 were downgrades. 6 analysts currently cover AUGX.
Analyst Recommendation Trends
AUGX analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 5 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$31M
↓ 41.9% YoY
Revenue Next Year
$52M
↑ 67.7% YoY
EPS This Year
$-0.65
EPS Next Year
$-0.47
↓ 27.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast AUGX EPS of $-0.65 for the current fiscal year, based on estimates from 1 analysts. The AUGX revenue forecast is $31M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The AUGX stock forecast is supported by two independent data sources: analyst consensus ratings from 6 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus AUGX price target is $2.67 (+13.6% upside), with an analyst consensus of Buy.
The AUGX short-term stock prediction for tomorrow is $2.35 (+0.12%).
Augmedix, Inc. trades on NASDAQ under the ticker AUGX. The AUGX stock outlook for 2027 is broadly positive, supported by a Buy consensus among 67% of covering analysts.
Frequently asked questions
AUGX forecast · 8 questionsAccording to 6 Wall Street analysts, the average 12-month AUGX price target is $2.67, with a high forecast of $3.50 and a low of $1.50. The median price target is shown in the chart above when available. This implies +13.6% potential upside from the current price of $2.35.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.